Skip to main content
Log in

Prolactin unresponsiveness to repeated sulpiride administration in man: recent findings

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The mechanism of prolactin (PRL) unresponsiveness to repeated sulpiride (SUL) administration was investigated by means of two experimental protocols. The first one was carried on in seven male volunteers (age 24 to 34 yr) and consisted of two phases separated by a 5-day interval. In both phases 1 mg/kg of SUL was given im and repeated, 24 h later, together with either placebo (PL, 2 ml saline iv) or TRH (200 µg iv). 7–10 days later a standard TRH test (200 µg iv) was performed. In the second protocol the usual dose (1 mg/Kg im) of SUL was administered alone and, 24 h later, together with 0.1 U/Kg iv of insulin (insulin tolerance test: ITT) to six male volunteers (age 20 to 32 yr). A control standard ITT (0.1 U/Kg iv) was also performed 7–10 days later. Plasma samples for the evaluation of PRL were taken in basal conditions and at regular intervals after each drug administration. In the first protocol, PRL shQwed a significant increase (peak values at 30 min) after SUL administration in both phases (phase A: 54.8 ± 5.6 ng/ml, mean ± SE vs 6.4 ± 0.3, p < 0.001. Phase B: 77.5 ± 3.9 vs 7.0 ± 0.6, p < 0.001). Twenty-four h later, PRL levels were still higher than basal and were not affected by the administration of SUL + PL or SUL + TRH. Also in the second protocol, SUL alone induced a significant PRL increase (peak values at 30 min: 47.1 ± 7.2 vs 4.2 ± 0.5, p < 0.005). Twenty-four h later PRL levels were still higher than in basal conditions (12.4 ± 1.5, p < 0.01 vs day one) and were modified by SUL + ITT administration only mildly (at 60 min: 17.0 ± 2.8, p < 0.05 vs basal) and significantly less than what observed after SUL and insulin alone (p < 0.005, p < 0.05, respectively). SUL then seems to induce a prolonged unresponsiveness of pituitary PRL secreting cells to multiple administration apparently not overcome by different stimuli (TRH, ITT), probably due to an alteration distal to the dopamine receptor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McNeil L.W., McKenna T.J., Lacroix A., Benveniste R., Rabin D. Seventy-two hour infusions of LHRH in normal men: gonadotropin and testicular steroid responses. J. Clin. Endocrinol: Metab. 49: 149, 1979.

    Article  CAS  Google Scholar 

  2. Rabin D., McNeil L.W. Pituitary and gonadal desensitization after continuous Luteinizing Hormone-Releasing Hormone infusion in normal females. J. Clin. Endocrinol. Metab. 51: 873, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Heber D., Swerdloff R.S. Down- regulation of pituitary gonadotropin secretion of postmenopausal females by continuous Gonadotropin-Releasing Hormone administration.. Clin. Endocrinol. Metab. 52: 171, 1981.

    Article  CAS  Google Scholar 

  4. Bergquist C., Nillius S.J., Wide L. Reduced gonadotropin secretions in postmenopausal women during treatment with a stimulatory LHRH analog. J. Clin. Endocrinol. Metab. 49: 472, 1979.

    Article  PubMed  CAS  Google Scholar 

  5. Mongioj A., Aliffi A., Vicari E., Coniglione F., Scapagnini U., D’Agata R. Down-regulation of prolactin secretion in men during continuous thyrotropin-releasing hormone infusion: evidence for induction of pituitary desensitization by continuous TRH administration. J. Clin. Endocrinol: Metab. 56: 904, 1983.

    Article  Google Scholar 

  6. Gelato M.C., D’Agata R., Pescovitz O., Loviaux D.L., Meniam G. Effect of continuous infusion of human growth hormone releasing factor (GRF) on GH in men. J. Endocrinol. Invest. 7(Suppl. 1): 5, 1984.

    Google Scholar 

  7. Webb C.B., Vance M., Thorner M.O., Perisutti G., Thominet J., Rivier J., Vale W., Frohman L.A. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. J. Clin. Invest. 74: 96, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Creese I., Sibley D.R., Left S., Hamblin M. Dopamine receptors: subtypes, localization and regulation. Fed. Proc. 40: 147, 1981.

    PubMed  CAS  Google Scholar 

  9. Cohen H., Pugeat M., Tourniaire J., Bertrand J. Unresponsiveness of prolactin to repeated injection of sulpiride in man. Eur. J. Clin. Pharmacol. 25: 275, 1983.

    Article  PubMed  CAS  Google Scholar 

  10. Justin-Besançon L., Thominet M., Laville C., Margarit J. Constitution chimique et propriétés biologiques du sulpiride. CR. Acad. Sci. Paris serie D. 265: 1253, 1967.

    Google Scholar 

  11. MacLeod R.M., Robyn C. Mechanism of increased prolactin secretion by sulpiride. J. Endocrinol. 72: 273, 1977.

    Article  PubMed  CAS  Google Scholar 

  12. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature 277: 93, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Sokoloff P., Martres M.P., Schwartz J.C. 3H-apomorphine lables both dopamine post-synaptic receptors and autoreceptors. Nature 288: 283, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Cote T.E., Crewe C.W., Tsuruta K., Stoof J.C., Esakay R.L., Kebabian J.W. D2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5′-triphosphate. Endocrinology 110: 812, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Besser G.M., Mortimer G.H. Clinical neuroendocrinology. In: Martini L., Ganong W.F. (Eds.) Frontiers in neuroendocrinology. Raven Press, New York, 1976, p. 227.

    Google Scholar 

  16. MacLeod R.M. Regulation of prolactin secretion. In: Martini L., Ganong W.F. (Eds.) Frontiers in neuroendocrinology. Raven Press, New York, 1976, p. 169.

    Google Scholar 

  17. Mancini A.M., Gutelman A., Vargas C.A., Debeljuk L., Aparicio N.J. Effect of sulpiride on serum PRL levels in humans. J. Clin. Endocrinol. Metab. 42: 181, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. L’Hermite M., Denayer P., Goldstein J., Virasoro E., Wanhaelst L., Copinshi G., Robyn C. Acute endocrine profile of sulpiride in the human. Clin. Endocrinol. (Oxf.) 9: 195, 1978.

    Article  Google Scholar 

  19. Jacobs L.S., Snyder P.J., Utiger R.D., Daughaday W.H. Prolactin response to thyrotropin-releasing hormone in normal subjects. J. Clin. Endocrinol. Metab. 36: 1069, 1973.

    Article  PubMed  CAS  Google Scholar 

  20. Porteus S.E., Malven P.V. Stimulation of prolactin release in vivo by thyrotropin-releasing hormone (TRH) through direct action in the ectopic rat pituitary. Endocrinology 94: 1699, 1974.

    Article  PubMed  CAS  Google Scholar 

  21. Murdoch G.H., Franco R., Evans R.M., Rosenfeld M.G. Polypeptide hormone regulation of gene expression. J. Biol. Chem. 258: 15329, 1983.

    PubMed  CAS  Google Scholar 

  22. Tan K.N., Tashjian A.H. Voltage-dependent calcium channels in pituitary cells in culture. J. Biol. Chem. 259: 427, 1984.

    PubMed  CAS  Google Scholar 

  23. Wilson R.G., Singhal V.K., Percy-Robb I., Forrest A.P.M. Response of plasma prolactin and growth hormone to insulin hypoglycemia. Lancet 2: 1283, 1972.

    Article  PubMed  CAS  Google Scholar 

  24. May P.B., Burrow G.N., Kayne R.D., Donabedian R.K. Hypoglycemia-induced prolactin release. Arch. Intern. Med. 138: 918, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Woolf P.D., Lee L.A., Leebaw W.F. Hypoglycemia as a provocative test of prolactin release. Metabolism 27: 869, 1978.

    Article  PubMed  CAS  Google Scholar 

  26. Buckman M.T., Peake G.T. Concordance of insulin-induced hypoglycemia and phenothiazine-induced prolactin secretion in man. J. Clin. Endocrinol. Metab. 48: 213, 1979.

    Article  PubMed  CAS  Google Scholar 

  27. Woolf P.D., Lee L.A., Leebaw W., Thompson D., Lilavivathana U., Brodows R., Campbell R. Intracellular glucopenia causes prolactin release in man. J. Clin. Endocrinol. Metab. 45: 377, 1977.

    Article  PubMed  CAS  Google Scholar 

  28. Prescott R.W.G., Kendall-Taylor T., Weightman D.R., Watson M.J., Ratcliffe W.A. The effect of ketanserin, a specific serotonin antagonist on the PRL, GH, ACTH and Cortisol responses to hypoglycemia in normal subjects. Clin. Endocrinol. (Oxf.) 20: 137, 1984.

    Article  CAS  Google Scholar 

  29. Nathan R.S., Sachar E.J., Ostrow L., Asnis G.M., Halbreich U., Halpem F.S. Failure of dopaminergic blockade to affect prolactin, growth hormone, and Cortisol responses to insulin-induced hypoglycemia in schizophrenics. J. Clin. Endocrinol. Metab. 52: 807, 1981.

    Article  PubMed  CAS  Google Scholar 

  30. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non carcinogenic chromogen. J. Clin. Pathol. 22: 158, 1969.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  31. Pontiroli A.E., Gala R.R., Pellicciotta G., De Pasqua A., Giraddi A.M., Pozza G. Study on the reproducibility of human prolactin response to sulpiride, benzerazide, insulin hypoglycemia and arginine infusion. Acta Endocrinol. (Kbh.) 91: 410, 1979.

    CAS  Google Scholar 

  32. Tormey W.P., Buckley M.P., Taaffe W., O’Kelly D.A., Darragh A. Prolactin, responsiveness to repeated decrementai doses of sulpiride. Horm. Metab. Res. 13: 454, 1981.

    Article  PubMed  CAS  Google Scholar 

  33. Mongioì A., Vicari E., Macchi M. Dynamics of prolactin response during continuous sulpiride infusion: desensitization of dopaminergic receptor? J. Endocrinol. Invest. 7(Suppl. 1): 45, 1984.

    Google Scholar 

  34. Gasperi M., Pucci E., Ramacciotti C., Del Corso L., Beeli M., Monacci F., Luisi M., Franchi F. Valutazione della riserva ipofisaria di prolattina in età senile: stimolazione con metoclopramide. Giornale Geront. 33: 563, 1985.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by funds from the National Research Council, Rome, Italy: Progetto finalizzato Medicina Preventiva e Riabilitativa. Sottoprogetto: Meccanismi d’Invecchiamento.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernini, G.P., Gasperi, M., Gravina, G. et al. Prolactin unresponsiveness to repeated sulpiride administration in man: recent findings. J Endocrinol Invest 10, 131–135 (1987). https://doi.org/10.1007/BF03347175

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347175

Key-words

Navigation